Stivarga 40 mg film-coated tablets
UC-0150/1309
Phase 2 small_molecule active
Quick answer
Stivarga 40 mg film-coated tablets for Bone sarcoma is a Phase 2 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cancer Prevention Pharma (Ireland) Limited
- Indication
- Bone sarcoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active